openPR Logo
Press release

Deadline on August 24th coming up in Lawsuit for Investors in shares of Athira Pharma, Inc. (NASDAQ: ATHA)

07-28-2021 08:38 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Shareholders Foundation

A Deadline is coming up on August 24, 2021 in the lawsuit for certain investors in Athira Pharma, Inc. (NASDAQ: ATHA).

A Deadline is coming up on August 24, 2021 in the lawsuit for certain investors in Athira Pharma, Inc. (NASDAQ: ATHA).

A deadline is coming up on August 24, 2021 in the lawsuit filed for certain investors of Athira Pharma, Inc. (NASDAQ: ATHA) over alleged securities laws violations by Athira Pharma, Inc.

Investors who purchased shares of Athira Pharma, Inc. (NASDAQ: ATHA) have certain options and there are strict and short deadlines running. Deadline: August 24, 2021. NASDAQ: ATHA stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

According to the complaint filed in the U.S. District Court for the Western District of Washington the plaintiff alleges on behalf of purchasers of Athira Pharma, Inc. (NASDAQ: ATHA) common shares between September 18, 2020 and June 17, 2021, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims the Registration Statement and that between September 18, 2020 and June 17, 202, the defendants made materially false and misleading statements and omitted to state that Dr. Kawas had published research papers containing improperly altered images while she was a graduate student, that this purported research was foundational to Athira's efforts to develop treatments for Alzheimer's because it laid the biological groundwork that Athira was using in its approach to treating Alzheimer's, that as a result, Athira's intellectual property and product development for the treatment of Alzheimer's was based on invalid research, and that as a result of the foregoing, the defendants' positive statements about Athira's business, operations, and prospects, were materially misleading and/or lacked a reasonable basis. Those who purchased shares of Athira Pharma, Inc. (NASDAQ: ATHA) have certain options and should contact the Shareholders Foundation.

Those who purchased shares of Athira Pharma, Inc. (NASDAQ: ATHA) have certain options and should contact the Shareholders Foundation.

Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Deadline on August 24th coming up in Lawsuit for Investors in shares of Athira Pharma, Inc. (NASDAQ: ATHA) here

News-ID: 2340218 • Views: 302

More Releases from Shareholders Foundation

Investigation announced for Long-Term Investors of Danimer Scientific, Inc. (NYS …
Certain directors of Danimer Scientific, Inc are under investigation over potential breaches of fiduciary duties. Investors who are current long term investors in Danimer Scientific, Inc. (NYSE: DNMR) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term investors in NYSE: DNMR stocks follows a lawsuit filed against Danimer Scientific, Inc. over alleged
Deadline on October 15th coming up in Lawsuit for Investors in Koninklijke Phili …
A deadline is coming up on October 15, 2021 in the lawsuit filed for certain investors of Koninklijke Philips N.V. (NYSE: PHG) over alleged securities laws violations by Koninklijke Philips N.V. Investors who purchased shares of Koninklijke Philips N.V. (NYSE: PHG) have certain options and there are strict and short deadlines running. Deadline: October 15, 2021. NYSE: PHG stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 -
Investigation announced for Long-Term Investors in NASDAQ: ARRY shares over poss …
An investigation was announced concerning potential breaches of fiduciary duties by certain directors of Array Technologies, Inc.. Investors who are current long term investors in Array Technologies, Inc. (NASDAQ: ARRY) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term investors in NASDAQ: ARRY stocks follows a lawsuit filed against Array Technologies, Inc.
Investigation announced for Investors in SmileDirectClub, Inc. (NASDAQ: SDC) ove …
An investigation was announced over potential breaches of fiduciary duties by certain directors at SmileDirectClub, Inc. Investors who purchased shares of SmileDirectClub, Inc. (NASDAQ: SDC) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain SmileDirectClub directors breached their fiduciary duties and caused damage to the company and its shareholders. Nashville, TN based SmileDirectClub, Inc. operates a

All 5 Releases